Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients

K. L. Juliëtte Schmidt(Princess Máxima Center), Wim J. E. Tissing(University Medical Center Groningen), Noël M M Dautzenberg(Princess Máxima Center), Rob van Binnendijk(National Institute for Public Health and the Environment), Caroline A. Lindemans(University Medical Center Utrecht), Stefan Nierkens(Utrecht University), Gaby Smits(National Institute for Public Health and the Environment), Peter M. Hoogerbrugge(Helios Klinikum Emil von Behring), Louis Bont(University Medical Center Utrecht)
Cancers
April 29, 2023
10.3390/cancers15092562
Cited by 17

Related Papers

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
|Nature|2015|1.1k
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554